82 research outputs found
Morphological and functional properties distinguish the substance P and gastrin-releasing peptide subsets of excitatory interneuron in the spinal cord dorsal horn
Excitatory interneurons account for the majority of neurons in the superficial dorsal horn, but despite their presumed contribution to pain and itch, there is still limited information about their organisation and function. We recently identified 2 populations of excitatory interneuron defined by expression of gastrin-releasing peptide (GRP) or substance P (SP). Here, we demonstrate that these cells show major differences in their morphological, electrophysiological, and pharmacological properties. Based on their somatodendritic morphology and firing patterns, we propose that the SP cells correspond to radial cells, which generally show delayed firing. By contrast, most GRP cells show transient or single-spike firing, and many are likely to correspond to the so-called transient central cells. Unlike the SP cells, few of the GRP cells had long propriospinal projections, suggesting that they are involved primarily in local processing. The 2 populations also differed in responses to neuromodulators, with most SP cells, but few GRP cells, responding to noradrenaline and 5-HT; the converse was true for responses to the μ-opioid agonist DAMGO. Although a recent study suggested that GRP cells are innervated by nociceptors and are strongly activated by noxious stimuli, we found that very few GRP cells receive direct synaptic input from TRPV1-expressing afferents, and that they seldom phosphorylate extracellular signal–regulated kinases in response to noxious stimuli. These findings indicate that the SP and GRP cells differentially process somatosensory information
Circuit dissection of the role of somatostatin in itch and pain
Stimuli that elicit itch are detected by sensory neurons that innervate the skin. This information is processed by the spinal cord; however, the way in which this occurs is still poorly understood. Here we investigated the neuronal pathways for itch neurotransmission, particularly the contribution of the neuropeptide somatostatin. We find that in the periphery, somatostatin is exclusively expressed in Nppb+ neurons, and we demonstrate that Nppb+somatostatin+ cells function as pruriceptors. Employing chemogenetics, pharmacology and cell-specific ablation methods, we demonstrate that somatostatin potentiates itch by inhibiting inhibitory dynorphin neurons, which results in disinhibition of GRPR+ neurons. Furthermore, elimination of somatostatin from primary afferents and/or from spinal interneurons demonstrates differential involvement of the peptide released from these sources in itch and pain. Our results define the neural circuit underlying somatostatin-induced itch and characterize a contrasting antinociceptive role for the peptide
The potential role of thioredoxin 1 and CD30 systems as multiple pathway targets and biomarkers in tumor therapy
Our progress in understanding pathological disease mechanisms has led to the identification of biomarkers that have had a considerable impact on clinical practice. It is hoped that the move from generalized to stratified approaches, with the grouping of patients into clinical/therapeutic subgroups according to specific biomarkers, will lead to increasingly more effective clinical treatments in the near future. This success depends on the identification of biomarkers that reflect disease evolution and can be used to predict disease state and therapy response, or represent themselves a target for treatment. Biomarkers can be identified by studying relationships between serum, tissue, or tumor microenvironment parameters and clinical or therapeutic parameters at onset and during the progression of the disease, using systems biology. Given that multiple pathways, such as those responsible for redox and immune regulation, are deregulated or altered in tumors, the future of tumor therapy could lie in the simultaneous targeting of these pathways using extracellular and intracellular targets and biomarkers. With this aim in mind, we evaluated the role of thioredoxin 1, a key redox regulator, and CD30, a cell membrane receptor, in immune regulation. Our results lead us to suggest that the combined use of these biomarkers provides more detailed information concerning the multiple pathways affected in disease and hence the possibility of more effective treatment
Generation of Power-Constrained Scan Tests and Its Difficulty
This paper proposes a test generation framework to generate stuck-at tests for a scan circuit under both peak shift and capture power limits. A concept of "complete fault efficiency under a power budget" is introduced, and it is pointed out that existing test-generation-based techniques for test power lack this completeness. Some analytical data obtained by using the proposed framework are presented to show the difficulty of generating test patterns that meet given limits for shift-in, shift-out and capture power, simultaneously. To relax the difficulty, this paper also describes a heuristic procedure using a cone analysis that definitely derives scan tests with low shift-in power and that reduces the search space during test generation. From the point of view discussed in this paper, further work should be undertaken in the future
Efficient path delay test generation based on stuck-at test generation using checker circuitry
This paper proposes an approach to non-robust and functionally sensitizable path delay test generation through stuck-at test generation. In this approach, to generate two-pattern tests for path delay faults in a combinational circuit, checker circuitry is constructed which is composed of logic gates corresponding to the mandatory assignments for detecting the faults. This checker circuitry allows us to use any existing combinational stuck-at test generation tool. Since today's stuck-at test generation tools reach a mature level, the proposed approach can efficiently solve the path delay test generation problem for combinational circuits. Experimental results show that the approach can speed up path delay test generation and can improve fault efficiency. This paper also discusses how a scan circuit and the issues of over-testing and test power are handled in the proposed test generation framework
Behavior of a Solid Particle Based on the Equation of Motion Under Oscillatory Motion of Progressive Waves
- …